Sunmax Biotechnology Co., Ltd. (4728.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$409.00 (+0.00%) as of
Key statistics
- Market cap
- 22.28B
- P/E (TTM)
- 26.58
- EPS (TTM)
- 15.39
- Dividend yield
- 3.06%
- 52-week range
- 350.00 – 416.00
- Beta
- -0.13
- Revenue (TTM)
- 2.19B
- Profit margin
- 36.97%
- Volume
- 11.00
About Sunmax Biotechnology Co., Ltd.
Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tainan City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.